Open questions about metabolically normal obesity

International Journal of Obesity

Volumn 34, Issue , 2010, Pages S18-S23

  Pataky, Z ^a   Bobbioni Harsch, E ^a   Golay, A ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Cardio metabolic complications; Metabolic normality; Metabolic syndrome

Indexed keywords

AGE DISTRIBUTION; ARTICLE; BODY FAT DISTRIBUTION; CARDIOVASCULAR RISK; DISEASE SURVEILLANCE; GENETICS; HUMAN; INSULIN SENSITIVITY; INTRAABDOMINAL FAT; LIFESTYLE; METABOLIC SYNDROME X; OBESITY; PHYSICAL ACTIVITY; PREVALENCE; PRIORITY JOURNAL; RACE DIFFERENCE; SEX RATIO;

BODY MASS INDEX; FEMALE; HEALTH STATUS; HUMANS; INSULIN RESISTANCE; INTRA-ABDOMINAL FAT; LIFE STYLE; MALE; METABOLIC SYNDROME X; OBESITY; RISK FACTORS; WEIGHT LOSS;

EID: 78650128005     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/ijo.2010.235     Document Type: Article

References (51)

1. Hubert HB, Feinleib M, McNamara PM, CastelliWP. Obesity as an independent risk factor for cardiovascular disease: A 26-year follow-up of participants in the Framingham Heart Study. Circulation 1983; 67: 968–977.
2. Calle EE, Thun MJ, Petrelli JM, Rodriguez C, Heath Jr CW. Bodymass index and mortality in a prospective cohort of US adults. N Engl J Med 1999; 341: 1097–1105.
3. Must A, Spadano J, Coakley EH, Field AE, Colditz G, Dietz WH. The disease burden associated with overweight and obesity. JAMA 1999; 282: 1523–1529.
4. Ferrannini E, Natali A, Bell P, Cavallo-Perin P, Lalic N, Mingrone G. Insulin resistance and hypersecretion in obesity. European Group for the Study of Insulin Resistance (EGIR). J Clin Invest 1997; 100: 1166–1173.
5. Brochu M, Tchernof A, Dionne IJ, Sites CK, Eltabbakh GH, Sims EA, What are the physical characteristics associated with a normal metabolic profile despite a high level of obesity in postmenopausal women? J Clin Endocrinol Metab 2001; 86: 1020–1025.
6. Karelis AD, Faraj M, Bastard JP, St-Pierre DH, Brochu M, Prudhomme D, The metabolically healthy but obese individual presents a favorable inflammation profile. J Clin Endocrinol Metab 2005; 90: 4145–4150.
7. McLaughlin T, Allison G, Abbasi F, Lamendola C, Reaven G. Prevalence of insulin resistance and associated cardiovascular disease risk factors among normal weight, overweight, and obese individuals. Metabolism 2004; 53: 495–499.
8. McLaughlin T, Abbasi F, Lamendola C, Reaven G. Heterogeneity in the prevalence of risk factors for cardiovascular disease and type 2 diabetes mellitus in obese individuals: Effect of differences in insulin sensitivity. Arch Intern Med 2007; 167: 642–648.
9. Bonora E, Kiechl S, Willeit J, Oberhollenzer F, Egger G, Targher G, Prevalence of insulin resistance in metabolic disorders: The Bruneck Study. Diabetes 1998; 47: 1643–1649.
10. Bonora E, Kiechl S, Willeit J, Oberhollenzer F, Egger G, Meigs JB, Insulin resistance as estimated by homeostasis model assessment predicts incident symptomatic cardiovascular disease in caucasian subjects from the general population: The Bruneck study. Diabetes Care 2007; 30: 318–324.
11. Reaven G. All obese individuals are not created equal: Insulin resistance is the major determinant of cardiovascular disease in overweight/obese individuals. Diab Vasc Dis Res 2005; 2: 105–112.
12. Iacobellis G, Ribaudo MC, Zappaterreno A, Iannucci CV, Leonetti F. Prevalence of uncomplicated obesity in an Italian obese population. Obes Res 2005; 13: 1116–1122.
13. Karelis AD, Brochu M, Rabasa-Lhoret R. Can we identify metabolically healthy but obese individuals (MHO)? Diabetes Metab 2004; 30: 569–572.
14. Stefan N, Kantartzis K, Machann J, Schick F, Thamer C, Rittig K, Identification and characterization of metabolically benign obesity in humans. Arch Intern Med 2008; 168: 1609–1616.
15. Marini MA, Succurro E, Frontoni S, Hribal ML, Andreozzi F, Lauro R, Metabolically healthy but obese women have an intermediate cardiovascular risk profile between healthy nonobese women and obese insulin-resistant women. Diabetes Care 2007; 30: 2145–2147.
16. Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: Comparison with the euglycemic insulin clamp. Diabetes Care 1999; 22: 1462–1470.
17. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412–419.
18. Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, Quantitative insulin sensitivity check index: A simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000; 85: 2402–2410.
19. Wildman RP, Muntner P, Reynolds K, McGinn AP, Rajpathak S, Wylie-Rosett J, The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: Prevalence and correlates of 2 phenotypes among the US population (NHANES 1999–2004). Arch Intern Med 2008; 168: 1617–1624.
20. Kuk JL, Ardern CI. Are metabolically normal but obese individuals at lower risk for all-cause mortality? Diabetes Care 2009; 32: 2297–2299.
21. Perseghin G, Ghosh S, Gerow K, Shulman GI. Metabolic defects in lean nondiabetic offspring of NIDDM parents: A cross-sectional study. Diabetes 1997; 46: 1001–1009.
22. Messier V, Karelis AD, Prudhomme D, Primeau V, Brochu M, Rabasa-Lhoret R. Identifying metabolically healthy but obese individuals in sedentary postmenopausal women. Obesity (Silver Spring) 2009; 18: 911–917.
23. Pataky Z, Bobbioni-Harsch E, Makoundou V, Carpentier A, Golay A. Does metabolically normal obesity exist? Obesity Facts 2009; 2 (2): 48.
24. Fox CS, Heard-Costa N, Cupples LA, Dupuis J, Vasan RS, Atwood LD. Genome-wide association to body mass index and waist circumference: The Framingham Heart Study 100K project. BMC Med Genet 2007; 8 (1): S18.
25. Kunnas T, Lahtio R, Kortelainen ML, Kalela A, Nikkari ST. Gln27Glu variant of Beta2-adrenoceptor gene affects male type fat accumulation in women. Lipids Health Dis 2009; 8: 43.
26. Peeters AV, Beckers S, Verrijken A, Mertens I, Roevens P, Peeters PJ, Association of SIRT1 gene variation with visceral obesity. Hum Genet 2008; 124: 431–436.
27. Levine JA, Eberhardt NL, Jensen MD. Role of nonexercise activity thermogenesis in resistance to fat gain in humans. Science 1999; 283: 212–214.
28. Choh AC, Demerath EW, Lee M, Williams KD, Towne B, Siervogel RM, Genetic analysis of self-reported physical activity and adiposity: The Southwest Ohio Family Study. Public Health Nutr 2009; 12: 1052–1060.
29. Dumke CL, Rhodes JS, Garland T, Maslowski E, Swallow JG, Wetter AC, Genetic selection of mice for high voluntary wheel running: Effect on skeletal muscle glucose uptake. J Appl Physiol 2001; 91: 1289–1297.
30. Dabelea D, Hanson RL, Lindsay RS, Pettitt DJ, Imperatore G, Gabir MM, Intrauterine exposure to diabetes conveys risks for type 2 diabetes and obesity: A study of discordant sibships. Diabetes 2000; 49: 2208–2211.
31. Gallou-Kabani C, Junien C. Nutritional epigenomics of metabolic syndrome: New perspective against the epidemic. Diabetes 2005; 54: 1899–1906.
32. Jennings CL, Lambert EV, Collins M, Joffe Y, Levitt NS, Goedecke JH. Determinants of insulin-resistant phenotypes in normal-weight and obese Black African women. Obesity (Silver Spring) 2008; 16: 1602–1609.
33. Diamant M, Lamb HJ, van de Ree MA, Endert EL, Groeneveld Y, Bots ML, The association between abdominal visceral fat and carotid stiffness is mediated by circulating inflammatory markers in uncomplicated type 2 diabetes. J Clin Endocrinol Metab 2005; 90: 1495–1501.
34. O’Connell J, Lynch L, Cawood TJ, Kwasnik A, Nolan N, Geoghegan J, The relationship of omental and subcutaneous adipocyte size to metabolic disease in severe obesity. PLoS One 2010; 5: E9997.
35. Drolet R, Belanger C, Fortier M, Huot C, Mailloux J, Legare D, Fat depot-specific impact of visceral obesity on adipocyte adiponectin release in women. Obesity (Silver Spring) 2009; 17: 424–430.
36. Aguilar-Salinas CA, Garcia EG, Robles L, Riano D, Ruiz-Gomez DG, Garcia-Ulloa AC, High adiponectin concentrations are associated with the metabolically healthy obese phenotype. J Clin Endocrinol Metab 2008; 93: 4075–4079.
37. Szendroedi J, Roden M. Ectopic lipids and organ function. Curr Opin Lipidol 2009; 20: 50–56.
38. McLaren L, Godley J, MacNairn IA. Social class, gender, and time use: Implications for the social determinants of body weight? Health Rep 2009; 20: 65–73.
39. Karelis AD, Fontaine J, Rabasa-Lhoret R, Prudhomme D, Doucet E, Blanchard C, Psychosocial profile of the metabolically healthy but obese postmenopausal woman. Diabetes Metab 2006; 32: 90–91.
40. Kyrou I, Chrousos GP, Tsigos C. Stress, visceral obesity, and metabolic complications. Ann N Y Acad Sci 2006; 1083: 77–110.
41. Meigs JB, Wilson PW, Fox CS, Vasan RS, Nathan DM, Sullivan LM, Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. J Clin Endocrinol Metab 2006; 91: 2906–2912.
42. Janssen I, Katzmarzyk PT, Ross R. Duration of overweight and metabolic health risk in American men and women. Ann Epidemiol 2004; 14: 585–591.
43. Muscelli E, Camastra S, Gastaldelli A, Natali A, Masoni A, Pecori N, Influence of duration of obesity on the insulin resistance of obese non-diabetic patients. Int J Obes Relat Metab Disord 1998; 22: 262–267.
44. Robinson MR, Scheuermann-Freestone M, Leeson P, Channon KM, Clarke K, Neubauer S, Uncomplicated obesity is associated with abnormal aortic function assessed by cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2008; 10: 10.
45. Oflaz H, Ozbey N, Mantar F, Genchellac H, Mercanoglu F, Sencer E, Determination of endothelial function and early atherosclerotic changes in healthy obese women. Diabetes Nutr Metab 2003; 16: 176–181.
46. Berrahmoune H, Herbeth B, Samara A, Marteau JB, Siest G, Visvikis-Siest S. Five-year alterations in BMI are associated with clustering of changes in cardiovascular risk factors in a genderdependant way: The Stanislas study. Int J Obes (Lond) 2008; 32: 1279–1288.
47. Shin MJ, Hyun YJ, Kim OY, Kim JY, Jang Y, Lee JH. Weight loss effect on inflammation and LDL oxidation in metabolically healthy but obese (MHO) individuals: Low inflammation and LDL oxidation in MHO women. Int J Obes (Lond) 2006; 30: 1529–1534.
48. Karelis AD, Messier V, Brochu M, Rabasa-Lhoret R. Metabolically healthy but obese women: Effect of an energy-restricted diet. Diabetologia 2008; 51: 1752–1754.
49. Rzehak P, Meisinger C, Woelke G, Brasche S, Strube G, Heinrich J. Weight change, weight cycling and mortality in the ERFORT Male Cohort Study. Eur J Epidemiol 2007; 22: 665–673.
50. Olson MB, Kelsey SF, Bittner V, Reis SE, Reichek N, Handberg EM, Weight cycling and high-density lipoprotein cholesterol in women: Evidence of an adverse effect: A report from the NHLBI-sponsored WISE study. Women0s Ischemia Syndrome Evaluation Study Group. J Am Coll Cardiol 2000; 36: 1565–1571.
51. Karelis AD, Brochu M, Rabasa-Lhoret R. Can we identify metabolically healthy but obese individuals (MHO)? Diabetes Metab 2004; 30: 569–572.